Non-Invasive Monitoring Systems (OTCMKTS:NIMU) and CHF Solutions (NASDAQ:CHFS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Analyst Recommendations

This is a summary of current recommendations and price targets for Non-Invasive Monitoring Systems and CHF Solutions, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Non-Invasive Monitoring Systems 0 0 0 0 N/A
CHF Solutions 0 0 1 0 3.00

CHF Solutions has a consensus price target of $3.30, indicating a potential downside of 4.35%. Given CHF Solutions’ higher probable upside, analysts plainly believe CHF Solutions is more favorable than Non-Invasive Monitoring Systems.

Insider & Institutional Ownership

84.0% of CHF Solutions shares are held by institutional investors. 28.8% of Non-Invasive Monitoring Systems shares are held by insiders. Comparatively, 7.3% of CHF Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Risk & Volatility

Non-Invasive Monitoring Systems has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500. Comparatively, CHF Solutions has a beta of 2.7, suggesting that its share price is 170% more volatile than the S&P 500.

Valuation & Earnings

This table compares Non-Invasive Monitoring Systems and CHF Solutions’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Non-Invasive Monitoring Systems $10,000.00 616.25 -$440,000.00 N/A N/A
CHF Solutions $5.00 million 0.46 -$17.03 million ($42.14) -0.08

Non-Invasive Monitoring Systems has higher earnings, but lower revenue than CHF Solutions.

Profitability

This table compares Non-Invasive Monitoring Systems and CHF Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Non-Invasive Monitoring Systems N/A N/A -660.39%
CHF Solutions -340.78% -185.30% -148.41%

Summary

CHF Solutions beats Non-Invasive Monitoring Systems on 6 of the 11 factors compared between the two stocks.

Non-Invasive Monitoring Systems Company Profile

Non-Invasive Monitoring Systems, Inc., together with its subsidiaries, engages in the research, development, manufacture, and marketing of a line of motorized, non-invasive, whole body, and periodic acceleration platforms in the United States and internationally. It offers Exer-Rest line of acceleration therapeutic platforms, including the Exer-Rest AT3800 and the Exer-Rest AT4700 models, which are whole body periodic acceleration therapeutic devices to healthy individuals, as well as for physicians and their patients. The company was incorporated in 1980 and is headquartered in Miami, Florida.

CHF Solutions Company Profile

CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It offers Aquadex FlexFlow consoles and the related disposable products in Singapore and Hong Kong. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.

Receive News & Ratings for Non-Invasive Monitoring Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Non-Invasive Monitoring Systems and related companies with MarketBeat.com's FREE daily email newsletter.